单细胞转录组测序在黑素瘤研究中的应用

doi:10.35541/cjd.20210191

中华皮肤科杂志 ›› 2023, Vol. 56 ›› Issue (10): 977-981.doi: 10.35541/cjd.20210191

单细胞转录组测序在黑素瘤研究中的应用

李婷婷关猛猛赵娟康晓静

新疆维吾尔自治区人民医院皮肤性病科新疆皮肤病临床医学研究中心新疆皮肤病研究重点实验室（XJYS1707），乌鲁木齐 830001

收稿日期:2021-03-04 修回日期:2022-03-14 发布日期:2023-10-08
通讯作者: 康晓静 E-mail:drkangxj666@163.com
基金资助:
新疆维吾尔自治区“天山创新团队计划”项目（2020D14006）；新疆维吾尔自治区自然科学基金（2021D01C201）

Application of single-cell RNA sequencing in melanoma research

Li Tingting, Guan Mengmeng, Zhao Juan, Kang Xiaojing

Department of Dermatology and Venereology, People′s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Dermatologic Diseases, Xinjiang Key Laboratory of Dermatology Research （XJYS1707）, Urumqi 830001, China

Received:2021-03-04 Revised:2022-03-14 Published:2023-10-08
Contact: Kang Xiaojing E-mail:drkangxj666@163.com
Supported by:
Autonomous Region Innovation Environment （Talent, Base） Construction Project “Tianshan Innovation Team Plan” （2020D14006）; Natural Science Foundation of Xinjiang Uygur Autonomous Region of China （2021D01C201）

摘要/Abstract

摘要： 【摘要】肿瘤异质性是黑素瘤组织的重要特征之一。单细胞转录组测序不仅能进一步揭示黑素瘤细胞异质性，且在分析黑素瘤发生发展规律、发现免疫治疗新靶点及揭示耐药机制等方面具有独特优势。本文综述单细胞转录组测序在黑素瘤研究中的应用。

关键词: 黑色素瘤, 序列分析, RNA, 转录组, 单细胞分析, 遗传异质性, 肿瘤微环境, 免疫疗法, 抗药性, 肿瘤, 单细胞转录组测序

Abstract: 【Abstract】 Tumor heterogeneity is one of the important characteristics of melanoma. Single-cell RNA sequencing can not only further reveal the heterogeneity of melanoma cells, but also has unique advantages in analyzing the occurrence and development of melanoma, finding new targets for immunotherapy and uncovering mechanisms of drug resistance. This review summarizes the application of single-cell transcriptome sequencing in melanoma research.

Key words: Melanoma, Sequence analysis, RNA, Transcriptome, Single-cell analysis, Genetic heterogeneity, Tumor microenvironment, Immunotherapy, Drug resistance, neoplasm, Single-cell RNA sequencing

李婷婷关猛猛赵娟康晓静. 单细胞转录组测序在黑素瘤研究中的应用[J]. 中华皮肤科杂志, 2023,56(10):977-981. doi:10.35541/cjd.20210191

Li Tingting, Guan Mengmeng, Zhao Juan, Kang Xiaojing. Application of single-cell RNA sequencing in melanoma research[J]. Chinese Journal of Dermatology, 2023, 56(10): 977-981.doi:10.35541/cjd.20210191

参考文献 42

［1］	Hu X, Hu Y, Wu F, et al. Integration of single⁃cell multi⁃omics for gene regulatory network inference［J］. Comput Struct Biotechnol J, 2020,18:1925⁃1938. doi: 10.1016/j.csbj.2020.06. 033.
［2］	Pratapa A, Jalihal AP, Law JN, et al. Benchmarking algorithms for gene regulatory network inference from single⁃cell transcriptomic data［J］. Nat Methods, 2020,17（2）:147⁃154. doi: 10.1038/s41592⁃019⁃0690⁃6.
［3］	朱容慧, 李巍. 单细胞RNA测序技术及其在皮肤病学研究中的应用［J］. 中华皮肤科杂志, 2019,52（7）:506⁃509. doi: 10. 3760/cma.j.issn.0412⁃4030.2019.07.015.
［4］	Puram SV, Tirosh I, Parikh AS, et al. Single⁃cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer［J］. Cell, 2017,171（7）:1611⁃1624. doi: 10.1016/j.cell.2017.10.044.
［5］	Mereu E, Lafzi A, Moutinho C, et al. Benchmarking single⁃cell RNA⁃sequencing protocols for cell atlas projects［J］. Nat Biotechnol, 2020,38（6）:747⁃755. doi: 10.1038/s41587⁃020⁃0469⁃4.
［6］	Lähnemann D, Köster J, Szczurek E, et al. Eleven grand challenges in single⁃cell data science［J］. Genome Biol, 2020,21（1）:31. doi: 10.1186/s13059⁃020⁃1926⁃6.
［7］	Savas P, Virassamy B, Ye C, et al. Single⁃cell profiling of breast cancer T cells reveals a tissue⁃resident memory subset associated with improved prognosis［J］. Nat Med, 2018,24（7）:986⁃993. doi: 10.1038/s41591⁃018⁃0078⁃7.
［8］	Mustachio LM, Roszik J. Opportunities for single⁃cell sequencing technologies and data science［J］. Cancers （Basel）, 2020,12（11）:3433. doi: 10.3390/cancers12113433.
［9］	Zhang L, Yu X, Zheng L, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer［J］. Nature, 2018,564（7735）:268⁃272. doi: 10.1038/s41586⁃018⁃0694⁃x.
［10］	Guo X, Zhang Y, Zheng L, et al. Global characterization of T cells in non⁃small⁃cell lung cancer by single⁃cell sequencing［J］. Nat Med, 2018,24（7）:978⁃985. doi: 10.1038/s41591⁃018⁃0045⁃3.
［11］	刘慧萍, 崔恒, 昌晓红. 单细胞测序技术在恶性肿瘤研究中的应用进展［J］. 中国肿瘤临床, 2020,47（7）:365⁃368. doi: 10. 3969/j.issn.1000⁃8179.2020.07.323.
［12］	Lin Z, Meng X, Wen J, et al. Intratumor heterogeneity correlates with reduced immune activity and worse survival in melanoma patients［J］. Front Oncol, 2020,10:596493. doi: 10.3389/fonc. 2020.596493.
［13］	Gerber T, Willscher E, Loeffler⁃Wirth H, et al. Mapping heterogeneity in patient⁃derived melanoma cultures by single⁃cell RNA⁃seq［J］. Oncotarget, 2017,8（1）:846⁃862. doi: 10. 18632/oncotarget.13666.
［14］	Tirosh I, Izar B, Prakadan SM, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single⁃cell RNA⁃seq［J］. Science, 2016,352（6282）:189⁃196. doi: 10.1126/science.aad0501.
［15］	Gokuldass A, Draghi A, Papp K, et al. Qualitative analysis of tumor⁃infiltrating lymphocytes across human tumor types reveals a higher proportion of bystander CD8（+） T cells in non⁃melanoma cancers compared to melanoma［J］. Cancers （Basel）, 2020,12（11）:3344. doi: 10.3390/cancers12113344.
［16］	Li H, van der Leun AM, Yofe I, et al. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma［J］. Cell, 2019,176（4）:775⁃789.e18. doi: 10.1016/j.cell.2018.11.043.
［17］	Carmona SJ, Siddiqui I, Bilous M, et al. Deciphering the transcriptomic landscape of tumor⁃infiltrating CD8 lymphocytes in B16 melanoma tumors with single⁃cell RNA⁃Seq［J］. Oncoimmunology, 2020,9（1）:1737369. doi: 10.1080/2162402X. 2020.1737369.
［18］	Davidson S, Efremova M, Riedel A, et al. Single⁃cell RNA sequencing reveals a dynamic stromal niche that supports tumor growth［J］. Cell Rep, 2020,31（7）:107628. doi: 10.1016/j.celrep.2020.107628.
［19］	Hirata E, Ishibashi K, Kohsaka S, et al. The brain microenvironment induces DNMT1 suppression and indolence of metastatic cancer cells［J］. iScience, 2020,23（9）:101480. doi: 10.1016/j.isci.2020.101480.
［20］	Wouters J, Kalender⁃Atak Z, Minnoye L, et al. Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma［J］. Nat Cell Biol, 2020,22（8）:986⁃998. doi: 10.1038/s41556⁃020⁃0547⁃3.
［21］	Li X, Karras P, Torres R, et al. Disseminated melanoma cells transdifferentiate into endothelial cells in intravascular niches at metastatic sites［J］. Cell Rep, 2020,31（11）:107765. doi: 10. 1016/j.celrep.2020.107765.
［22］	Hamid O, Robert C, Daud A, et al. Five⁃year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE⁃001［J］. Ann Oncol, 2019,30（4）:582⁃588. doi: 10.1093/annonc/mdz011.
［23］	Dai WF, Beca JM, Croxford R, et al. Real⁃world comparative effectiveness of second⁃line ipilimumab for metastatic melanoma: a population⁃based cohort study in Ontario, Canada［J］. BMC Cancer, 2020,20（1）:304. doi: 10.1186/s12885⁃020⁃06798⁃1.
［24］	Helmink BA, Reddy SM, Gao J, et al. B cells and tertiary lymphoid structures promote immunotherapy response［J］. Nature, 2020,577（7791）:549⁃555. doi: 10.1038/s41586⁃019⁃1922⁃8.
［25］	Xiong D, Wang Y, You M. A gene expression signature of TREM2（hi） macrophages and γδ T cells predicts immunotherapy response［J］. Nat Commun, 2020,11（1）:5084. doi: 10.1038/s41467⁃020⁃18546⁃x.
［26］	Schetters S, Rodriguez E, Kruijssen L, et al. Monocyte⁃derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy［J］. J Immunother Cancer, 2020,8（2）:e000588. doi: 10.1136/jitc⁃2020⁃000588.
［27］	Kim K, Park S, Park SY, et al. Single⁃cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti⁃PD⁃1 responses in human cancer［J］. Genome Med, 2020,12（1）:22. doi: 10.1186/s13073⁃020⁃00722⁃9.
［28］	Sade⁃Feldman M, Yizhak K, Bjorgaard SL, et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma［J］. Cell, 2018,175（4）:998⁃1013.e20. doi: 10. 1016/j.cell.2018.10.038.
［29］	Singer M, Wang C, Cong L, et al. A distinct gene module for dysfunction uncoupled from activation in tumor⁃infiltrating T cells［J］. Cell, 2016,166（6）:1500⁃1511.e9. doi: 10.1016/j.cell. 2016.08.052.
［30］	Nirschl CJ, Suárez⁃Fariñas M, Izar B, et al. IFNγ⁃dependent tissue⁃immune homeostasis is co⁃opted in the tumor microenvironment［J］. Cell, 2017,170（1）:127⁃141.e15. doi: 10. 1016/j.cell.2017.06.016.
［31］	Jerby⁃Arnon L, Shah P, Cuoco MS, et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade［J］. Cell, 2018,175（4）:984⁃997. doi: 10.1016/j.cell.2018.09.006.
［32］	Shaffer SM, Dunagin MC, Torborg SR, et al. Rare cell variability and drug⁃induced reprogramming as a mode of cancer drug resistance［J］. Nature, 2017,546（7658）:431⁃435. doi: 10.1038/nature22794.
［33］	Rambow F, Rogiers A, Marin⁃Bejar O, et al. Toward minimal residual disease⁃directed therapy in melanoma［J］. Cell, 2018,174（4）:843⁃855.e19. doi: 10.1016/j.cell.2018.06.025.
［34］	Long JE, Wongchenko MJ, Nickles D, et al. Therapeutic resistance and susceptibility is shaped by cooperative multi⁃compartment tumor adaptation［J］. Cell Death Differ, 2019,26（11）:2416⁃2429. doi: 10.1038/s41418⁃019⁃0310⁃0.
［35］	Prieto⁃Fernández E, Egia⁃Mendikute L, Bosch A, et al. Hypoxia promotes syndecan⁃3 expression in the tumor microenvironment［J］. Front Immunol, 2020,11:586977. doi: 10.3389/fimmu.2020. 586977.
［36］	Fairfax BP, Taylor CA, Watson RA, et al. Peripheral CD8（+） T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma［J］. Nat Med, 2020,26（2）:193⁃199. doi: 10.1038/s41591⁃019⁃0734⁃6.
［37］	Peng H, Zeng X, Zhou Y, et al. A component overlapping attribute clustering （COAC） algorithm for single⁃cell RNA sequencing data analysis and potential pathobiological implications［J/OL］. PLoS Comput Biol, 2019,15（2）:e1006772. doi: 10.1371/journal.pcbi.1006772.
［38］	Slyper M, Porter C, Ashenberg O, et al. A single⁃cell and single⁃nucleus RNA⁃Seq toolbox for fresh and frozen human tumors［J］. Nat Med, 2020,26（5）:792⁃802. doi: 10.1038/s41591⁃020⁃0844⁃1.
［39］	Tsoucas D, Dong R, Chen H, et al. Accurate estimation of cell⁃type composition from gene expression data［J］. Nat Commun, 2019,10（1）:2975. doi: 10.1038/s41467⁃019⁃10802⁃z.
［40］	Ho YJ, Anaparthy N, Molik D, et al. Single⁃cell RNA⁃seq analysis identifies markers of resistance to targeted BRAF inhibitors in melanoma cell populations［J］. Genome Res, 2018,28（9）:1353⁃1363. doi: 10.1101/gr.234062.117.
［41］	Cheng C, Easton J, Rosencrance C, et al. Latent cellular analysis robustly reveals subtle diversity in large⁃scale single⁃cell RNA⁃seq data［J］. Nucleic Acids Res, 2019,47（22）:e143. doi: 10. 1093/nar/gkz826.
［42］	Song Y, Xu X, Wang W, et al. Single cell transcriptomics: moving towards multi⁃omics［J］. Analyst, 2019,144（10）:3172⁃3189. doi: 10.1039/c8an01852a.

[1]	陈春里闫思聿王丹高丽华谭丽娜唐四元刘伟曾金容鲁建云. 酸化脂肪酸酯治疗特应性皮炎样模型小鼠的疗效及机制初探[J]. 中华皮肤科杂志, 2023, 56(9): 822-831.
[2]	岳超段梦莹王涛章满玉戴叶芹彭建中宋秀祖. 上睑眼轮匝肌岛状皮瓣修复眼睑及眶周皮肤肿瘤切除后继发缺损28例回顾性分析[J]. 中华皮肤科杂志, 2023, 56(9): 862-865.
[3]	董栋刘天一. 细胞代谢与皮肤恶性黑素瘤转移的研究进展[J]. 中华皮肤科杂志, 2023, 56(9): 878-881.
[4]	谌芳琪梁闫吴婷黄长征. m6A RNA甲基化与皮肤黑素瘤相关性的研究进展[J]. 中华皮肤科杂志, 2023, 56(9): 889-892.
[5]	袁心刚倪思利张建罗晓燕王华. 儿童黑素细胞痣的诊疗水平亟待提高[J]. 中华皮肤科杂志, 2023, 56(8): 782-786.
[6]	唐志铭荆梦晴陆鹭单霄张翠侠张晓宇孟飒. 犀地凉血方通过LncRNA NEAT1/miR-485-5p/ STAT3调控网络对HaCaT细胞增殖、凋亡影响的研究[J]. 中华皮肤科杂志, 2023, 56(7): 642-650.
[7]	《蕈样肉芽肿治疗中国专家共识》编写专家组. [开放获取] 蕈样肉芽肿治疗中国专家共识（2023）[J]. 中华皮肤科杂志, 2023, 56(5): 402-409.
[8]	张聪聪陈浩. Spitz样肿瘤的研究进展[J]. 中华皮肤科杂志, 2023, 56(5): 463-467.
[9]	陈怡宋秀祖. 瞬时受体电位通道在黑素细胞中的作用及相关疾病研究[J]. 中华皮肤科杂志, 2023, 56(4): 376-379.
[10]	连盼盼刘军苏忠兰王宏伟. 过氧化物酶体增殖物激活受体γ对皮肤生理功能和病理过程的影响[J]. 中华皮肤科杂志, 2023, 56(4): 365-368.
[11]	丁高中刘梦茜马伟李姗姗孙澜陈朝潮. 甲母质细胞癌1例[J]. 中华皮肤科杂志, 2023, 0(3): 20230124-e0230124.
[12]	杨永婷李婷婷康晓静. 黑素瘤免疫检查点抑制剂治疗相关的生物标志物研究进展[J]. 中华皮肤科杂志, 2023, 56(3): 278-283.
[13]	张嘉琪吴凡韩雨晴刘琦盘瑶. 多光子显微镜在皮肤科中的应用[J]. 中华皮肤科杂志, 2023, 0(2): 20230022-e20230022.
[14]	谢德琼杨开颖杨旸陈思源吉毅. 长链非编码RNA在婴幼儿血管瘤中的研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20210400-e20210400.
[15]	杨爱民成将伟黄嘉诚岑瑛陈俊杰. Merkel细胞癌治疗新进展[J]. 中华皮肤科杂志, 2023, 0(2): 20210536-e20210536.

单细胞转录组测序在黑素瘤研究中的应用

Application of single-cell RNA sequencing in melanoma research

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 42

相关文章 15

Metrics

本文评价

推荐阅读 10